Salvatore Fregola

Dr. Salvatore Fregola

R&D, EthosLab, Catanzaro, Calabria, Italy
+3
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
Raffaele SerraRaffaele Serra
Raffaele Serra
NINicola Ielapi
Nicola Ielapi
ABAndrea Bitonti
Andrea Bitonti
SCStefano Candido
Stefano Candido
SFSalvatore Fregola
Salvatore Fregola
Luca GallelliLuca Gallelli
Luca Gallelli
Chronic Venous Disease (CVD) is a common medical condition affecting up to 80% of the general population. Clinical manifestations can range from mild to more severe signs and symptoms that contribute to the impairment of the quality of life (QoL) of affected patients. Among treatment options, venoactive drugs such as diosmin are widely used in the symptomatic treatment in all clinical stages. The aim of this study is to determine the effectiveness of a new formulated diosmin in relieving symptoms and improving QoL in patients suffering from CVD. In this randomized, double-blind, placebo-controlled, multicenter clinical study, CVD patients with a Clinical-Etiology-Anatomy-Pathophysiology (CEAP) classification system between C2 and C4 were randomized to receive a bioavailable diosmin (as μsmin® Plus) 450 mg tablet once daily or a placebo for 8 weeks. Clinical symptoms and QoL were monitored using the measurement of leg circumference, visual analogue scale (VAS) for pain, Global Index Score (GIS) and Venous Clinical Severity Score (VCSS). A total of 72 subjects completed the study. From week 4, leg edema was significantly decreased in the active group (p < 0.001). An improvement in the VAS score was observed in the active group compared to placebo at the end of treatment (p < 0.05). GIS and VCSS scores were significantly improved in the active group at week 8 (p < 0.001). No treatment related-side effects were recorded. The results of this study showed that the administration of low-dose μsmin® Plus was safe and effective in relieving symptoms and improving QoL in subjects with CVD.

6 November 2015 in International Wound Journal
Verified
Journal Article
Closed access
PDF file
SFStefano de Franciscis
Stefano de Franciscis
SFSalvatore Fregola
Salvatore Fregola
AGAlessandro Gallo
Alessandro Gallo
GAGiuseppe Argirò
Giuseppe Argirò
ABAndrea Barbetta
Andrea Barbetta
Raffaele SerraRaffaele Serra
Raffaele Serra

1 August 2020 in International Wound Journal
Verified
Journal Article
Closed access
PDF file
Raffaele SerraRaffaele Serra
Raffaele Serra
UBUmberto Bracale
Umberto Bracale
ABAndrea Barbetta
Andrea Barbetta
NINicola Ielapi
Nicola Ielapi
NLNoemi Licastro
Noemi Licastro
SFStefano de Franciscis
Stefano de Franciscis

17 January 2023 in COVID
Verified
Journal Article
Open access
PDF file
AGAlessandro Gallo
Alessandro Gallo
SFSalvatore Fregola
Salvatore Fregola
MMMargherita Menon
Margherita Menon
FTFilomena Talarico
Filomena Talarico
SFStella Fragkiadaki
Stella Fragkiadaki
TMThe Si4Care Partners Members
The Si4Care Partners Members
The SI4CARE project is a transnational project which aims to develop both strategy and action plans to improve health and social care in the Adriatic–Ionian region. Starting from a survey of the status quo, each partner has developed some pilots to support the development and monitoring of the policy actions. In particular, partner number three, the Municipality of Miglierina, designed and developed a pilot related to the use of wearable devices for monitoring elderly patients in rural areas. With the collaboration of the complex unity of primary care (UCCP) of the Reventino area, the pilot is based on the use of smart wearable devices to monitor some parameters of older adults after their vaccinations for flu and covid. This paper focused on the design and implementation of the system. It describes its application in the Municipality of Miglierina. Presentation of the results and a discussion of the strengths and weaknesses will be presented, in detail, in future work. Finally, the possibility of extending the experiment to other Adriatic–Ionian regions is addressed.

21 May 2020 in Global Clinical Engineering Journal
Verified
Journal Article
Open access
PDF file
FPFrancesca Pristerà
Francesca Pristerà
AGAlessandro Gallo
Alessandro Gallo
SFSalvatore Fregola
Salvatore Fregola
Alessio MEROLAAlessio MEROLA
Alessio MEROLA
This work investigates the validity and reliability of a novel biomechatronic device providing an interactive environment in Augmented Reality (AR) for neuromotor rehabilitation. A RGB-depth camera and telemonitoring/remote signaling module are the main components of the device, together with a PC-based interface. The interactive environment, which implements some optimized algorithms of body motion capture and novel methodologies for human body motion analysis, enables neuromotor rehabilitation treatments that are adaptable to the performance and individual characteristics of the patient. The RGB-Depth camera module is implemented through a Microsoft Kinect, ORBBEC ZED2K devices; the telemonitoring module for teleassistance and therapy supervision is implemented as a cloud service. Within the module of body motion tracking, the abduction and adduction movements of the limbs of the full-body structure are tracked and the joints angles are measured in real-time; the most distinctive feature of the tracking module is the control of the trunk and shoulder posture during the exercises performed by the patient. Indeed, the device recognizes an incorrect position of the patient's body that could affect the objective of the exercise to be performed. The recognition of an incorrect exercise is associated to the generation of an alert both to the patient and the physician, in order to maximize the effectiveness of the treatment based on the user's potential and to increase the chances of a better biofeedback. The experimental tests, which have been carried out by reproducing several neuromotor exercises on the interactive environment, show that the feature recognition and extraction of the joints and segments of the musculo-skeletal structure of the patient's, and of wrong posture during exercises, can achieve good performance in the different experimental conditions. The developed device is a valid tool for patients affected by chronic disability, but it could be extended to neurodegenerative diseases in the early stages of the disease. Thanks to the enhanced interactivity in augmented reality, the patient can overcome some difficulties in interaction with the most common IT tools and technologies; at the meanwhile she/he can perform rehabilitation at home. The physician can also check in real time the results and customize the care pathway. The enhanced interactivity provided by the device during rehabilitation session increases both the motivation by the patient and the continuity of the care, as well as it supports low-cost remote assistance and telemedicine by optimizing therapy costs. The key points are: i) making rehabilitation motivating for the patient, becoming a "player"; ii) optimize effectiveness and costs; iii) possibility of low-cost remote assistance and telemedicine.

29 January 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
AGAlessandro Gallo
Alessandro Gallo
SFSalvatore Fregola
Salvatore Fregola
MMMargherita Menon
Margherita Menon
FTFilomena Talarico
Filomena Talarico
SFStella Fragkiadaki
Stella Fragkiadaki
Pietro Hiram GuzziPietro Hiram Guzzi
Pietro Hiram Guzzi
The improvement of health and social care needs the introduction of shared solution at transnational level. The SI4CARE (Social Innovation for Integrated Health Care) project is a transnational initiative within the Adriatic-Ionian regions aiming to develop strategies to improve the current status of health and social care. The Municipality of Miglierina, a small rural town in Calabria, which is a member the project, is developing a pilot action related to the use of wearable device for monitoring people affected by dementia with the project partner Ra.Gi.. Ra.Gi. is a non-profit organization dedicated to assisting people with dementia in day care centers and so-called dementia-friendly communities. The pilot is based on the use of smart wearable devices to monitor these patients during their daily lifetime. This paper focuses on the design and implementation of the system discussing the proposed application, the strengths and weaknesses. Finally, the possibility of extending the experiment to the other Adriatic-Ionian region is presented.